India  

Russia to sell 100 million doses of Covid-19 vaccine to India

IndiaTimes Wednesday, 16 September 2020 ()
Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19 once it receives regulatory approval. Clinical trials of the Russian vaccine in India are expected to follow, held jointly with the Indian firm. Both the trials and supply deal depends on domestic regulatory approval.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Tommy DeVito, Original Four Seasons Member, Dead at 92 from COVID

Tommy DeVito -- one of the original members of the iconic Doo-Wop group, The Four Seasons -- has died from coronavirus. 'Casino' actor Alfredo Nittoli confirmed..
TMZ.com
Covid: ‘50 lakh cases but almost 45 lakh recoveries’, says Health Secretary [Video]

Covid: ‘50 lakh cases but almost 45 lakh recoveries’, says Health Secretary

With India recording the highest number of COVID-19 recoveries in the world, the government on Tuesday said that for the past four consecutive days the number of daily recovered cases surpassed the new infections reported per day. Addressing a press briefing, Union Health Ministry Secretary Rajesh Bhushan said India has the highest number of recovered cases in the world at 44,97,867. "India's COVID-19 cases share is 17.7 per cent of global infections, while those who have recuperated are 19.5 per cent of total recoveries in world. The daily recoveries from COVID-19 more than number of new infections reported per day since past four consecutive days," he said.

Credit: HT Digital Content    Duration: 14:51Published

Gam-COVID-Vac Gam-COVID-Vac Viral vector vaccine candidate based on human adenovirus

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks

Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at..
DNA

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: Dr Reddy's

Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the..
IndiaTimes

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company..
DNA

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on..
IndiaTimes
Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer [Video]

Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer

Equity benchmark indices traded higher in the afternoon session on September 16 while Asian stocks were flat ahead of the US Federal Reserve's view on the economy. The BSE S-P Sensex closed 259 points or 0.66 per cent at 39,303 while the Nifty 50 gained by 83 points or 0.72 per cent at 11,605. Except for Nifty media and PSU bank, all sectoral indices at the National Stock Exchange were in the positive zone with Nifty realty gaining by 2.2 per cent, pharma by 2 per cent and auto by 1.5 per cent. Among stocks, Dr Reddy's jumped by 4.44 per cent to close at Rs 4,639.60 per share after it announced cooperation with Russian Direct Investment Fund (RDIF) to conduct clinical trials and distribute Sputnik V vaccine in India for treatment of COVID-19. Mahindra - Mahindra accelerated by 4 per cent to Rs 638.05 per share while Bajaj Auto moved up by 3.5 per cent and Tata Motors by 1.7 per cent.

Credit: ANI    Duration: 01:21Published

Dr. Reddy's Laboratories Indian multinational pharmaceutical company

Equity indices trade higher, pharma stocks rally [Video]

Equity indices trade higher, pharma stocks rally

Equity benchmark indices traded higher during early hours on Friday amid mixed cues from their Asian peers. At 10:15 am, the BSE S-P Sensex was up by 136 points or 0.35 per cent at 39,115 while the Nifty 50 moved up by 56 points or 0.48 per cent at 11,576. Except for Nifty FMCG, all sectoral indices at the National Stock Exchange were in the green with Nifty pharma gaining by 3.8 per cent, realty by 0.9 per cent and auto by 0.7 per cent. Among stocks, Dr Reddy's Laboratories jumped by 4.6 per cent to Rs 5,051.20 per share after the company said it has settled its patent litigation with Celgene for the latter's cancer drug capsules. Cipla ticked up by 5.4 per cent and Sun Pharma by 3 per cent while Oberoi Realty advanced by 2.4 per cent. Eicher Motors, Adani Ports, Tech Mahindra and Wirpo traded with a positive bias. FMCG stocks fell with Hindustan Uniliver slipping by 1.4 per cent, Nestle India by 0.3 per cent and Britannia by 0.2 per cent.

Credit: ANI    Duration: 01:24Published

Related videos from verified sources

Coronavirus: India's Covid tally past 54 lakh with over 86 lakh cases reported in 24 hours|Oneindia [Video]

Coronavirus: India's Covid tally past 54 lakh with over 86 lakh cases reported in 24 hours|Oneindia

India has reached another grim milestone in its battle against the Coronavirus Pandemic with the Covid tally past 54 lakhs. 86,961 cases were recorded in the last 24 hours with the total cases of 54,..

Credit: Oneindia     Duration: 01:21Published
If all goes well, expect COVID vaccine by early next year: AIIMS doctor [Video]

If all goes well, expect COVID vaccine by early next year: AIIMS doctor

As clinical trials of different COVID-19 vaccines are in various phases across the globe, an AIIMS (All India Institute of Medical Sciences) doctor said that if everything goes as planned, people can..

Credit: ANI     Duration: 02:26Published
‘Flattening of Covid-19 curve requires collaborative efforts’: Harsh Vardhan [Video]

‘Flattening of Covid-19 curve requires collaborative efforts’: Harsh Vardhan

Union Health Minister Harsh vardhan spoke at a joint meeting with G20 finance and health ministers. Harsh Vardhan said that flattening of the curve requires collaborative efforts. "Current pandemic..

Credit: HT Digital Content     Duration: 04:24Published

Related news from verified sources

Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses

Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's...
DNA

Russia to sell 100 million doses of Covid-19 vaccine to India

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19...
IndiaTimes Also reported by •newKerala.com

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company...
DNA


Tweets about this

NIRUPAMACHARJE1

NIRUPAM Dr Reddy's Lab @drreddys must double check before collaborating with the Russian #COVID19 Vaccine #Sputnik V for cl… https://t.co/L117hviRAN 5 hours ago

Mrityun76416996

Mrityunjoy Barman RT @the_hindu: Just in | Russia has signed a deal with Dr Reddy's to test and supply the Sputnik V #vaccine in India. Dr Reddy's to conduct… 12 hours ago

Ashutos44225212

Ashutosh Paul RT @ieexplained: #ExpressExplained | What is the Sputnik V vaccine, and is it likely to come to India anytime soon? @PrabhaRaghavan writes… 15 hours ago

SWillerup

Sarah Willerup Russia COVID-19 Vaccine: Russia To Sell 100 Million Doses Of Sputnik-V Vaccine To Dr Reddy's Lab https://t.co/O9AL2nacSy 23 hours ago

ieexplained

Express Explained #ExpressExplained | What is the Sputnik V vaccine, and is it likely to come to India anytime soon? @PrabhaRaghavan… https://t.co/uztJn1GrSh 1 day ago

deshmukh_dk

Dinesh Deshmukh RT @vikiitd: When large US/EU pharma companies r struggling .. I wonder how Russia is ready with the Sputnik Covid vaccine in such short ti… 1 day ago

login_rameshk

kumar ramesh RT @AtanuDa88541113: Big breaking news on COViD19 vaccine update. Trust this succeeds in normalizing life and livelihood. @DrReddysLabs @I… 1 day ago

vikiitd

Vikas V When large US/EU pharma companies r struggling .. I wonder how Russia is ready with the Sputnik Covid vaccine in su… https://t.co/ZusthfnCih 1 day ago